Prudential PLC lessened its stake in shares of Integer Holdings Corp (NYSE:ITGR) by 28.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 157,025 shares of the medical equipment provider’s stock after selling 63,675 shares during the period. Prudential PLC owned 0.48% of Integer worth $11,975,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Castleark Management LLC purchased a new stake in shares of Integer in the 3rd quarter valued at approximately $15,613,000. Sawgrass Asset Management LLC grew its stake in shares of Integer by 102.2% in the 4th quarter. Sawgrass Asset Management LLC now owns 32,740 shares of the medical equipment provider’s stock valued at $2,497,000 after buying an additional 16,550 shares during the period. SG Americas Securities LLC grew its stake in shares of Integer by 118.3% in the 3rd quarter. SG Americas Securities LLC now owns 102,863 shares of the medical equipment provider’s stock valued at $8,532,000 after buying an additional 55,749 shares during the period. Rhumbline Advisers grew its stake in shares of Integer by 22.3% in the 4th quarter. Rhumbline Advisers now owns 87,495 shares of the medical equipment provider’s stock valued at $6,672,000 after buying an additional 15,979 shares during the period. Finally, MetLife Investment Advisors LLC grew its stake in shares of Integer by 40.7% in the 3rd quarter. MetLife Investment Advisors LLC now owns 21,497 shares of the medical equipment provider’s stock valued at $1,783,000 after buying an additional 6,222 shares during the period. Hedge funds and other institutional investors own 94.97% of the company’s stock.
NYSE:ITGR opened at $85.82 on Thursday. The company has a debt-to-equity ratio of 0.84, a current ratio of 2.53 and a quick ratio of 1.37. The company has a market cap of $2.79 billion, a P/E ratio of 22.58 and a beta of 1.01. Integer Holdings Corp has a fifty-two week low of $54.20 and a fifty-two week high of $92.61.
Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 21st. The medical equipment provider reported $1.04 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.92 by $0.12. The firm had revenue of $303.00 million during the quarter, compared to analysts’ expectations of $301.25 million. Integer had a net margin of 12.88% and a return on equity of 12.56%. The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter last year, the company posted $0.96 EPS. As a group, equities analysts forecast that Integer Holdings Corp will post 4.2 EPS for the current year.
ITGR has been the subject of several analyst reports. TheStreet raised shares of Integer from a “c+” rating to a “b-” rating in a research note on Monday, December 17th. Zacks Investment Research raised shares of Integer from a “hold” rating to a “buy” rating and set a $91.00 price target for the company in a research note on Friday, January 18th. Finally, Royal Bank of Canada increased their price target on shares of Integer from $84.00 to $92.00 and gave the company a “sector perform” rating in a research note on Monday, February 25th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $89.40.
In related news, insider Jose Antonio Gonzalez sold 9,088 shares of the stock in a transaction that occurred on Thursday, February 28th. The shares were sold at an average price of $90.88, for a total transaction of $825,917.44. Following the completion of the transaction, the insider now owns 11,899 shares of the company’s stock, valued at approximately $1,081,381.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.60% of the company’s stock.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Featured Story: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.